Guardion Health Sciences Inc (GHSI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.2200 -0.0700 (-2.13%) 10/30/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 3.2200 unch (unch) -
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 533 | -14,922 | -2,468 | -1,645 | -5,301 |
| Depreciation Amortization | 5 | 11,315 | 971 | 634 | 341 |
| Accounts receivable | -22 | -94 | -42 | -170 | -787 |
| Accounts payable and accrued liabilities | -630 | 1,277 | 799 | N/A | N/A |
| Other Working Capital | -550 | -1,893 | -1,315 | -1,358 | -95 |
| Other Operating Activity | -1,216 | -3,129 | -4,028 | -2,261 | 3,615 |
| Operating Cash Flow | $-1,879 | $-7,447 | $-6,083 | $-4,801 | $-2,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -6 | -6 | -2 | -2 |
| Purchase Of Investment | N/A | -77,592 | -77,592 | -61,957 | -21,977 |
| Sale Of Investment | N/A | 82,587 | 82,587 | 56,946 | 14,976 |
| Investing Cash Flow | $-2 | $4,990 | $4,990 | $-5,014 | $-7,004 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 9,969 | 9,969 | 9,969 | 9,969 |
| Common Stock Repurchased | N/A | -9 | N/A | N/A | N/A |
| Other Financing Activity | -5,250 | 4,308 | -24 | -24 | 0 |
| Financing Cash Flow | $-5,250 | $14,268 | $9,945 | $9,945 | $9,969 |
| Beginning Cash Position | 15,906 | 4,094 | 4,094 | 4,094 | 4,094 |
| End Cash Position | 8,775 | 15,906 | 12,946 | 4,225 | 4,833 |
| Net Cash Flow | $-7,131 | $11,812 | $8,852 | $131 | $739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,879 | -7,447 | -6,083 | -4,801 | -2,227 |
| Capital Expenditure | -2 | -6 | -6 | -2 | -2 |
| Free Cash Flow | -1,881 | -7,452 | -6,089 | -4,803 | -2,229 |